Skip to main content
VCbacked
Log inGet Started

Trio Pharmaceuticals

San Diego, United States

Trio Pharmaceuticals is a cancer therapeutics company that develops dual-action drugs for immunogenic tumors.

$3.1M raised
Dec 2024
Seed
BiotechnologyHealth CareMedicalTherapeutics

Top Investors

NuFund Venture GroupTech Coast AngelsMyeloma Investment FundLife Science AngelsSeedFolio

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Trio Pharmaceuticals

How much funding has Trio Pharmaceuticals raised?
Trio Pharmaceuticals has raised $3.1M in total funding. The most recent round was Seed. The last funding was announced in December 2024.
Who are Trio Pharmaceuticals's investors?
Trio Pharmaceuticals's investors include NuFund Venture Group, Tech Coast Angels, Myeloma Investment Fund, Life Science Angels, SeedFolio.
Where is Trio Pharmaceuticals headquartered?
Trio Pharmaceuticals is headquartered in San Diego, United States.
What does Trio Pharmaceuticals do?
Trio Pharmaceuticals is a cancer therapeutics company that develops dual-action drugs for immunogenic tumors.
What stage is Trio Pharmaceuticals at?
Trio Pharmaceuticals is at the Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Trio Pharmaceuticals — Funding & Investors." VCBacked, December 3, 2024, https://www.vcbacked.co/company/trio-pharmaceuticals. Accessed June 17, 2026.
APA
VCBacked. (2024). Trio Pharmaceuticals — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/trio-pharmaceuticals
Wikipedia (cite web)
{{cite web |title=Trio Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/trio-pharmaceuticals |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong